Proniras
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotech
- Founded
- 2018 Seattle business license
- Type
- Corporation Seattle business license
- Registered name
- Proniras Corporation Seattle business license
- Members see funding amounts. .
Is this your organization? Claim it
Recent coverage
Front-page news, podcasts and videos about Proniras
Proniras launches in Seattle to develop Eli Lilly’s tezampanel, wins $89.5M BARDA contract
Proniras Corporation launched in Seattle to develop tezampanel, a seizure drug originally created by Eli Lilly, and secured an $89.5 million BARDA contract contingent on development milestones. The company also received undisclosed launch funding from several investors, will be led by co-founder and CSO Chris Toombs, and plans to explore tezampanel as both a seizure therapy and a nerve-agent antidote.
Questions about Proniras
What is Proniras?
Seattle, WA, US
Where is Proniras based?
Proniras is headquartered in Seattle, WA, US.
When was Proniras founded?
Proniras was founded in 2018.